MILLER EDWARD (General Counsel) sold 0.8% of their position (52.00 shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $494.03 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2025ACC: 0000950170-25-009205
Officer· General Counsel
Since Jul 2020
-52.00
Net shares
Net seller
$494.03
Total sold
2
Open market trades
0B · 2S
2
Total transactions
52.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−47.00
Price / share
$9.45
Trade value
$444.33
% of position
0.7%
1/23/2025
6.67K→6.63K
Common Stock
Direct
Shares
−5.00
Price / share
$9.94
Trade value
$49.70
% of position
0.1%
1/23/2025
6.63K→6.62K
Total
Net shares
−52.00
Net value
-$494.03
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | S · Sale | −47.00 | $9.45 | $444.33 | 0.7% | 6.67K | 6.63K |
| Common Stock Direct | 1/23/2025 | S · Sale | −5.00 | $9.94 | $49.70 | 0.1% | 6.63K | 6.62K |
| Total | −52.00 | -$494.03 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.06K
Total
15.06K indirect15.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.06K | Indirect |
| Total | 15.06K | 15.06K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported